for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. authorizes additional batch of J&J COVID-19 vaccine manufactured by Emergent

July 2 (Reuters) - The U.S. Food and Drug Administration said on Friday it had authorized the use of an additional batch of Johnson & Johnson’s COVID-19 vaccine manufactured at the problem-plagued Baltimore factory of Emergent BioSolutions Inc.

Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up